Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The reiterated 'Buy' rating and maintained price target for Phathom Pharmaceuticals by Needham analyst Joseph Stringer indicates a positive outlook for the company, which could potentially lead to an increase in its stock price in the short term.